279 related articles for article (PubMed ID: 17222905)
1. The involvement of the central cholinergic system in the pressor and bradycardic effects of centrally administrated melittin in normotensive conscious rats.
Yalcin M; Erturk M
Neuropeptides; 2007 Apr; 41(2):103-10. PubMed ID: 17222905
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effect of peripheral injected melittin in normotensive conscious rats: Mediation of the central cholinergic system.
Yalcin M; Aydin C; Savci V
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):341-7. PubMed ID: 19910175
[TBL] [Abstract][Full Text] [Related]
3. The involvement of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats.
Yalcin M; Cavun S; Yilmaz MS; Savci V
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):31-40. PubMed ID: 16133489
[TBL] [Abstract][Full Text] [Related]
4. Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats.
Yalcin M; Cavun S; Yilmaz MS; Savci V
Brain Res; 2006 Nov; 1118(1):43-51. PubMed ID: 16962568
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms.
Yalcin M; Savci V
Neuropeptides; 2007 Dec; 41(6):465-75. PubMed ID: 17897713
[TBL] [Abstract][Full Text] [Related]
6. The mediation of the central histaminergic system in the pressor effect of intracerebroventricularly injected melittin, a phospholipase A2 activator, in normotensive rats.
Altinbas B; Topuz BB; Yilmaz MS; Aydin C; Savci V; Jochem J; Aydin S; Yalcin M
Prostaglandins Leukot Essent Fatty Acids; 2012; 87(4-5):153-8. PubMed ID: 22995146
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
Savci V; Cavun S; Goktalay G; Ulus IH
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
[TBL] [Abstract][Full Text] [Related]
8. The role of the central thromboxane A2 in cardiovascular effects of a phospholipase A2 activator melittin administrated intracerebroventricularly in normotensive conscious rats.
Yalcin M; Ak F; Erturk M
Neuropeptides; 2006 Jun; 40(3):207-12. PubMed ID: 16524625
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic neurons and the cardiovascular response produced by central injection of substance P in the normotensive rat.
Trimarchi GR; Glisson WC; Thomson WM; VanLingen J; Buccafusco JJ
Life Sci; 1986 Oct; 39(17):1579-88. PubMed ID: 2429134
[TBL] [Abstract][Full Text] [Related]
11. Centrally administered choline increases plasma prolactin levels in conscious rats.
Gürün MS; Savci V; Ulus IH; Kiran BK
Neurosci Lett; 1997 Aug; 232(2):79-82. PubMed ID: 9302091
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of central choline during endotoxin shock in the rat.
Savci V; Ulus IH
J Cardiovasc Pharmacol; 1997 Nov; 30(5):667-75. PubMed ID: 9388050
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
Isbil-Buyukcoskun N; Gulec G
Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
[TBL] [Abstract][Full Text] [Related]
14. Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation.
Cavun S; Savci V; Ulus IH
Fundam Clin Pharmacol; 2004 Feb; 18(1):71-7. PubMed ID: 14748757
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of centrally injected tetrahydroaminoacridine in conscious normotensive rats.
Savci V; Gürün MS; Cavun S; Ulus IH
Eur J Pharmacol; 1998 Apr; 346(1):35-41. PubMed ID: 9617749
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats.
Caputi AP; Rossi F; Carney K; Brezenoff HE
J Pharmacol Exp Ther; 1980 Nov; 215(2):309-16. PubMed ID: 7441497
[TBL] [Abstract][Full Text] [Related]
17. Modulation of nesfatin-1-induced cardiovascular effects by the central cholinergic system.
Aydin B; Guvenc G; Altinbas B; Niaz N; Yalcin M
Neuropeptides; 2018 Aug; 70():9-15. PubMed ID: 29751997
[TBL] [Abstract][Full Text] [Related]
18. A central link between angiotensinergic and cholinergic systems; role of vasopressin.
Buyukcoskun NI; Gulec G; Ozluk K
Peptides; 2001 Sep; 22(9):1415-20. PubMed ID: 11514022
[TBL] [Abstract][Full Text] [Related]
19. Central mechanism underlying pressor and bradycardic effect of intracerebroventricularly injected arachidonic acid.
Yalcin M
Can J Physiol Pharmacol; 2011 Feb; 89(2):127-33. PubMed ID: 21326344
[TBL] [Abstract][Full Text] [Related]
20. The role of brain acetylcholine in GABAA receptor antagonist-induced blood-pressure changes in rat.
Tellioğlu T; Akin S; Ozkutlu U; Oktay S; Onat F
Eur J Pharmacol; 1996 Dec; 317(2-3):301-7. PubMed ID: 8997614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
